Tissue Engineering of a Differentiated Cardiac Muscle Construct

Article Properties
  • Language
    English
  • Publication Date
    2002/02/08
  • Indian UGC (Journal)
  • Refrences
    41
  • Citations
    581
  • W.-H. Zimmermann From the Institute of Experimental and Clinical Pharmacology and Toxicology (W.-H.Z., K.S., P.S., M.D., F.M., T.E.) and the Institute of Anatomy (W.L.N.), Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany; the Institute of Pharmacology and Toxicology (J.F.H.), Dresden University of Technology, Dresden, Germany; and the Department of Experimental Cardiology (S.K.), Max-Planck-Institute, Bad Nauheim, Germany.
  • K. Schneiderbanger From the Institute of Experimental and Clinical Pharmacology and Toxicology (W.-H.Z., K.S., P.S., M.D., F.M., T.E.) and the Institute of Anatomy (W.L.N.), Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany; the Institute of Pharmacology and Toxicology (J.F.H.), Dresden University of Technology, Dresden, Germany; and the Department of Experimental Cardiology (S.K.), Max-Planck-Institute, Bad Nauheim, Germany.
  • P. Schubert From the Institute of Experimental and Clinical Pharmacology and Toxicology (W.-H.Z., K.S., P.S., M.D., F.M., T.E.) and the Institute of Anatomy (W.L.N.), Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany; the Institute of Pharmacology and Toxicology (J.F.H.), Dresden University of Technology, Dresden, Germany; and the Department of Experimental Cardiology (S.K.), Max-Planck-Institute, Bad Nauheim, Germany.
  • M. Didié From the Institute of Experimental and Clinical Pharmacology and Toxicology (W.-H.Z., K.S., P.S., M.D., F.M., T.E.) and the Institute of Anatomy (W.L.N.), Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany; the Institute of Pharmacology and Toxicology (J.F.H.), Dresden University of Technology, Dresden, Germany; and the Department of Experimental Cardiology (S.K.), Max-Planck-Institute, Bad Nauheim, Germany.
  • F. Münzel From the Institute of Experimental and Clinical Pharmacology and Toxicology (W.-H.Z., K.S., P.S., M.D., F.M., T.E.) and the Institute of Anatomy (W.L.N.), Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany; the Institute of Pharmacology and Toxicology (J.F.H.), Dresden University of Technology, Dresden, Germany; and the Department of Experimental Cardiology (S.K.), Max-Planck-Institute, Bad Nauheim, Germany.
  • J.F. Heubach From the Institute of Experimental and Clinical Pharmacology and Toxicology (W.-H.Z., K.S., P.S., M.D., F.M., T.E.) and the Institute of Anatomy (W.L.N.), Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany; the Institute of Pharmacology and Toxicology (J.F.H.), Dresden University of Technology, Dresden, Germany; and the Department of Experimental Cardiology (S.K.), Max-Planck-Institute, Bad Nauheim, Germany.
  • S. Kostin From the Institute of Experimental and Clinical Pharmacology and Toxicology (W.-H.Z., K.S., P.S., M.D., F.M., T.E.) and the Institute of Anatomy (W.L.N.), Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany; the Institute of Pharmacology and Toxicology (J.F.H.), Dresden University of Technology, Dresden, Germany; and the Department of Experimental Cardiology (S.K.), Max-Planck-Institute, Bad Nauheim, Germany.
  • W.L. Neuhuber From the Institute of Experimental and Clinical Pharmacology and Toxicology (W.-H.Z., K.S., P.S., M.D., F.M., T.E.) and the Institute of Anatomy (W.L.N.), Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany; the Institute of Pharmacology and Toxicology (J.F.H.), Dresden University of Technology, Dresden, Germany; and the Department of Experimental Cardiology (S.K.), Max-Planck-Institute, Bad Nauheim, Germany.
  • T. Eschenhagen From the Institute of Experimental and Clinical Pharmacology and Toxicology (W.-H.Z., K.S., P.S., M.D., F.M., T.E.) and the Institute of Anatomy (W.L.N.), Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany; the Institute of Pharmacology and Toxicology (J.F.H.), Dresden University of Technology, Dresden, Germany; and the Department of Experimental Cardiology (S.K.), Max-Planck-Institute, Bad Nauheim, Germany.
Abstract
Cite
Zimmermann, W.-H., et al. “Tissue Engineering of a Differentiated Cardiac Muscle Construct”. Circulation Research, vol. 90, no. 2, 2002, pp. 223-30, https://doi.org/10.1161/hh0202.103644.
Zimmermann, W.-H., Schneiderbanger, K., Schubert, P., Didié M., Münzel F., Heubach, J., Kostin, S., Neuhuber, W., & Eschenhagen, T. (2002). Tissue Engineering of a Differentiated Cardiac Muscle Construct. Circulation Research, 90(2), 223-230. https://doi.org/10.1161/hh0202.103644
Zimmermann WH, Schneiderbanger K, Schubert P, Didié M, Münzel F, Heubach J, et al. Tissue Engineering of a Differentiated Cardiac Muscle Construct. Circulation Research. 2002;90(2):223-30.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the blood and blood-forming organs
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the circulatory (Cardiovascular) system
Medicine
Medicine (General)
Description

Can we build a better heart outside the body? This innovative research explores the creation of engineered heart tissue (EHT) exhibiting key characteristics of differentiated myocardium. Cardiac myocytes from neonatal rats are combined with collagen I and matrix factors, molded into rings, and subjected to mechanical stretch, resulting in ring-shaped EHTs. Comparative histological analysis reveals that the cardiac cells in EHTs form interconnected muscle bundles resembling adult heart tissue. Confocal and electron microscopy confirm the presence of highly organized sarcomeres and other features of differentiated myocardium. EHTs demonstrate contractile characteristics and action potential recordings similar to native myocardium. The results suggest EHTs represent a promising material for in vitro studies of cardiac function and potential tissue replacement therapy. This work highlights the potential of cardiac tissue engineering to revolutionize cardiac research and treatment.

Published in _Circulation Research_, a leading journal in cardiovascular science, this article highlights cutting-edge research in cardiac tissue engineering. The study's focus on creating functional cardiac muscle constructs aligns perfectly with the journal's mission to advance understanding and treatment of heart disease.

Refrences
Citations
Citations Analysis
The first research to cite this article was titled Perfusion Improves Tissue Architecture of Engineered Cardiac Muscle and was published in 2002. The most recent citation comes from a 2024 study titled Perfusion Improves Tissue Architecture of Engineered Cardiac Muscle . This article reached its peak citation in 2016 , with 39 citations.It has been cited in 255 different journals, 17% of which are open access. Among related journals, the Biomaterials cited this research the most, with 26 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year